A recent Law 360 story by Sarah Jarvis, “Robbins Geller Nabs $13.5M in Puma Biotech Investor Suit” reports that a California federal judge has granted lawyers with Robbins Geller Rudman & Dowd LLP more than $13.5 million in attorney fees along with final approval for a $54.2 million settlement for investors who alleged Puma Biotechnology Inc. misstated the effectiveness of a breast cancer treatment. 

In an order, U.S. District Judge David O. Carter also approved an award of $2.8 million in expenses, plus interest on that award and the attorney fee award.  The court also approved more than $64,000 for lead plaintiff Norfolk County Council, which administers the Norfolk Pension Fund.